- Home
- PBBK vs SER Comparison
PBBK vs SER Comparison
Compare PBBK & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- SER
- Stock Information
- Founded
- PBBK 1919
- SER 2017
- Country
- PBBK United States
- SER United States
- Employees
- PBBK N/A
- SER N/A
- Industry
- PBBK Banks
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- SER Health Care
- Exchange
- PBBK Nasdaq
- SER Nasdaq
- Market Cap
- PBBK 45.2M
- SER 53.1M
- IPO Year
- PBBK N/A
- SER 2018
- Fundamental
- Price
- PBBK $19.42
- SER $4.61
- Analyst Decision
- PBBK
- SER Strong Buy
- Analyst Count
- PBBK 0
- SER 2
- Target Price
- PBBK N/A
- SER $13.00
- AVG Volume (30 Days)
- PBBK 16.0K
- SER 340.0K
- Earning Date
- PBBK 11-12-2025
- SER 11-11-2025
- Dividend Yield
- PBBK N/A
- SER N/A
- EPS Growth
- PBBK 42.12
- SER N/A
- EPS
- PBBK 0.95
- SER N/A
- Revenue
- PBBK $13,359,000.00
- SER $130,000.00
- Revenue This Year
- PBBK N/A
- SER $17.23
- Revenue Next Year
- PBBK N/A
- SER N/A
- P/E Ratio
- PBBK $20.43
- SER N/A
- Revenue Growth
- PBBK 12.31
- SER N/A
- 52 Week Low
- PBBK $14.05
- SER $3.81
- 52 Week High
- PBBK $20.07
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- PBBK 53.36
- SER 35.97
- Support Level
- PBBK $19.14
- SER $4.90
- Resistance Level
- PBBK $19.57
- SER $5.25
- Average True Range (ATR)
- PBBK 0.30
- SER 0.27
- MACD
- PBBK -0.08
- SER -0.05
- Stochastic Oscillator
- PBBK 35.37
- SER 4.94
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.